Literature DB >> 7746911

The aetiology of severe community-acquired pneumonia and its impact on initial, empiric, antimicrobial chemotherapy.

C Feldman1, S Ross, A G Mahomed, J Omar, C Smith.   

Abstract

Of 259 patients admitted to an intensive care unit with severe acute community-acquired pneumonia, 173 had primary infections and 86 had secondary infections. The commonest organism isolated in each group was Streptococcus pneumoniae (51.3 and 36.6% of known isolates in each group respectively). Klebsiella pneumoniae was the next most common isolate (31.9 and 29.3% respectively). A variety of other Gram-negative organisms and Staphylococcus aureus accounted for most of the remaining pathogens. Based on retrospective analysis of data, there appeared to be no difference in the alcohol consumption of patients with infection due to S. pneumoniae and K. pneumoniae. The overall mortality rate for the primary infections was 47.4%, with 68.4% of these infections due to K. pneumoniae and 33.9% due to the pneumococcus (P < 0.002). Among the secondary infections, the overall mortality rate was 40.8% (not significantly different to that of primary infections) with 45.5% due to K. pneumoniae and 23.1% due to the pneumococcus (not significantly different on statistical analysis, probably due to low patient numbers). Our investigation confirms that severe community-acquired pneumonia due to K. pneumoniae is extremely common, even in patients without obvious risk factors for Gram-negative colonization. This organism is contributing to the high mortality rate seen in our intensive care unit among patients with pneumonia, and our empiric therapy for such cases routinely includes a combination of agents active against this organism (e.g. a cephalosporin and an aminoglycoside).

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7746911     DOI: 10.1016/0954-6111(95)90246-5

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  14 in total

1.  BTS Guidelines for the Management of Community Acquired Pneumonia in Adults.

Authors: 
Journal:  Thorax       Date:  2001-12       Impact factor: 9.139

Review 2.  Clinical, bacteriological, and serological aspects of Klebsiella infections and their spondylarthropathic sequelae.

Authors:  H Sahly; R Podschun
Journal:  Clin Diagn Lab Immunol       Date:  1997-07

Review 3.  Severe community-acquired pneumonia: what do we need to know to effectively manage patients?

Authors:  M S Niederman
Journal:  Intensive Care Med       Date:  1996-12       Impact factor: 17.440

Review 4.  Defining severe pneumonia.

Authors:  Samuel M Brown; Nathan C Dean
Journal:  Clin Chest Med       Date:  2011-07-12       Impact factor: 2.878

Review 5.  Klebsiella pneumoniae: Going on the Offense with a Strong Defense.

Authors:  Michelle K Paczosa; Joan Mecsas
Journal:  Microbiol Mol Biol Rev       Date:  2016-06-15       Impact factor: 11.056

6.  SPLUNC1/BPIFA1 contributes to pulmonary host defense against Klebsiella pneumoniae respiratory infection.

Authors:  Yang Liu; Jennifer A Bartlett; Marissa E Di; Jennifer M Bomberger; Yvonne R Chan; Lokesh Gakhar; Rama K Mallampalli; Paul B McCray; Y Peter Di
Journal:  Am J Pathol       Date:  2013-03-15       Impact factor: 4.307

Review 7.  Defining and predicting severe community-acquired pneumonia.

Authors:  Samuel M Brown; Nathan C Dean
Journal:  Curr Opin Infect Dis       Date:  2010-04       Impact factor: 4.915

8.  Can we predict which patients with community-acquired pneumonia are likely to have positive blood cultures?

Authors:  Samuel George Campbell; R Andrew McIvor; Vincent Joanis; David Graydon Urquhart
Journal:  World J Emerg Med       Date:  2011

9.  Virulence characteristics of Klebsiella and clinical manifestations of K. pneumoniae bloodstream infections.

Authors:  Victor L Yu; Dennis S Hansen; Wen Chien Ko; Asia Sagnimeni; Keith P Klugman; Anne von Gottberg; Herman Goossens; Marilyn M Wagener; Vicente J Benedi
Journal:  Emerg Infect Dis       Date:  2007-07       Impact factor: 6.883

10.  Community-acquired Klebsiella pneumoniae bacteremia: global differences in clinical patterns.

Authors:  Wen-Chien Ko; David L Paterson; Anthanasia J Sagnimeni; Dennis S Hansen; Anne Von Gottberg; Sunita Mohapatra; Jose Maria Casellas; Herman Goossens; Lutfiye Mulazimoglu; Gordon Trenholme; Keith P Klugman; Joseph G McCormack; Victor L Yu
Journal:  Emerg Infect Dis       Date:  2002-02       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.